Spark Investment Management’s Navidea Biopharmaceuticals NAVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NAVB
Spark Investment Management's NAVB Position: Q4 2017 in Review
Spark Investment Management sold out of Navidea Biopharmaceuticals (NAVB) in Q4 2017, closing a stake of 5,312 shares — an estimated $44K sold.
Spark Investment Management first reported a position in NAVB in Q3 2016 and held it in 5 quarters. The position peaked at $284K in Q1 2017. 54 funds tracked by Wall St. Rank hold NAVB as of Q4 2017.
- Spark Investment Management reported no remaining Navidea Biopharmaceuticals position as of Q4 2017 after selling out during the quarter.
- Spark Investment Management sold 5,312 Navidea Biopharmaceuticals shares in Q4 2017, an estimated $44K.
- Spark Investment Management first reported a position in Navidea Biopharmaceuticals in Q3 2016 and held it in 5 quarters.
- Spark Investment Management's Navidea Biopharmaceuticals position peaked at $284K in Q1 2017.
- 54 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals as of Q4 2017.
Based on Spark Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.